USANA Health Sciences Reports Fiscal Year and Fourth Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St futures slip as oil surge puts markets on edge
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
USANA Health Sciences (USNA) Misses Q4 EPS by 25c
February 8, 2022 4:18 PM ESTUSANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.03, $0.25 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $267 million versus the consensus estimate of $271.93 million.
GUIDANCE:
USANA Health Sciences sees FY2022 EPS of $5.25-$6.00, versus the... More
